Assenagon Asset Management’s PTC Therapeutics PTCT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $6.61M | Sell |
|
|||||
|
2025
Q2 | $30.8M | Buy |
|
|||||
|
2025
Q1 | $17.2M | Sell |
|
|||||
|
2024
Q4 | $19.8M | Sell |
|
|||||
|
2024
Q3 | $18.3M | Buy |
|
|||||
|
2024
Q2 | $11.4M | Buy |
|
|||||
|
2024
Q1 | $8.91M | Buy |
|
|||||
|
2023
Q4 | $6.69M | Buy |
|
|||||
|
2023
Q3 | $1.17M | Buy |
|
|||||
|
2023
Q2 | $235K | Sell |
|
|||||
|
2023
Q1 | $924K | Sell |
|
|||||
|
2022
Q4 | $6.6M | Buy |
|
|||||
|
2022
Q3 | $6.49M | Buy |
|
|||||
|
2022
Q2 | $386K | Sell |
|
|||||
|
2022
Q1 | $4.14M | Buy |
|
|||||
|
2021
Q4 | $764K | Buy |
|
|||||
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $3.43M | Hold |
|
|||||
|
2020
Q4 | $4.42M | Sell |
|
|||||
|
2020
Q3 | $12.5M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $4.93M | Buy |
|